Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
- PMID: 26314532
- DOI: 10.1016/j.jacc.2015.06.1323
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
Abstract
Background: The incidence, predictors, and prognostic impact of post-discharge bleeding (PDB) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation are unclear.
Objectives: This study sought to characterize the determinants and consequences of PDB after PCI.
Methods: The prospective ADAPT-DES (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) study was used to determine the incidence and predictors of clinically relevant bleeding events occurring within 2 years after hospital discharge. The effect of PDB on subsequent 2-year all-cause mortality was estimated by time-adjusted Cox proportional hazards regression.
Results: Among 8,582 "all-comers" who underwent successful PCI with DES in the ADAPT-DES study, PDB occurred in 535 of 8,577 hospital survivors (6.2%) at a median time of 300 days (interquartile range: 130 to 509 days) post-discharge. Gastrointestinal bleeding (61.7%) was the most frequent source of PDB. Predictors of PDB included older age, lower baseline hemoglobin, lower platelet reactivity on clopidogrel, and use of chronic oral anticoagulation therapy. PDB was associated with higher crude rates of all-cause mortality (13.0% vs. 3.2%; p < 0.0001). Following multivariable adjustment, PDB was strongly associated with 2-year mortality (hazard ratio [HR]: 5.03; p < 0.0001), with an effect size greater than that of post-discharge myocardial infarction (PDMI) (HR: 1.92; p = 0.009).
Conclusions: After successful PCI with DES in an unrestricted patient population, PDB is not uncommon and has a strong relationship with subsequent all-cause mortality, greater that that associated with PDMI. Efforts to reduce PDB may further improve prognosis after successful DES implantation. (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents [ADAPT-DES]; NCT00638794).
Keywords: late bleeding; mortality; platelet reactivity.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
The Shifting Pendulum for DAPT After PCI: Balancing Long-Term Risks for Bleeding and Thrombosis.J Am Coll Cardiol. 2015 Sep 1;66(9):1046-9. doi: 10.1016/j.jacc.2015.07.015. J Am Coll Cardiol. 2015. PMID: 26314533 No abstract available.
Similar articles
-
Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).Circ Cardiovasc Interv. 2017 Mar;10(3):e004904. doi: 10.1161/CIRCINTERVENTIONS.116.004904. Circ Cardiovasc Interv. 2017. PMID: 28288963
-
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).JACC Cardiovasc Interv. 2015 Dec 28;8(15):1978-1987. doi: 10.1016/j.jcin.2015.08.032. JACC Cardiovasc Interv. 2015. PMID: 26738669
-
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.Lancet. 2013 Aug 17;382(9892):614-23. doi: 10.1016/S0140-6736(13)61170-8. Epub 2013 Jul 26. Lancet. 2013. PMID: 23890998 Clinical Trial.
-
[Optimal platelet inhibition after coronary stent implantation. Current status].Herz. 2008 Jun;33(4):244-53. doi: 10.1007/s00059-008-3138-9. Herz. 2008. PMID: 18581073 Review. German.
-
Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.Catheter Cardiovasc Interv. 2018 Jul;92(1):1-15. doi: 10.1002/ccd.27255. Epub 2017 Sep 12. Catheter Cardiovasc Interv. 2018. PMID: 28895303
Cited by
-
Efficacy and safety of bivalirudin application during primary percutaneous coronary intervention in older patients with acute ST-segment elevation myocardial infarction.J Int Med Res. 2020 Sep;48(9):300060520947942. doi: 10.1177/0300060520947942. J Int Med Res. 2020. PMID: 32985292 Free PMC article.
-
Update on Antithrombotic Therapy after Percutaneous Coronary Intervention.Intern Med. 2020 Feb 1;59(3):311-321. doi: 10.2169/internalmedicine.3685-19. Epub 2019 Oct 7. Intern Med. 2020. PMID: 31588089 Free PMC article. Review.
-
Assessing the Utility of the DAPT Score and PRECISE-DAPT Score in Determining the Appropriateness of Dual Antiplatelet Therapy in Patients With Acute Myocardial Infarction/Percutaneous Coronary Intervention.Cardiol Res Pract. 2024 Oct 30;2024:1489008. doi: 10.1155/2024/1489008. eCollection 2024. Cardiol Res Pract. 2024. PMID: 39512265 Free PMC article.
-
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention.US Cardiol. 2020 May 15;14:e04. doi: 10.15420/usc.2019.02. eCollection 2020. US Cardiol. 2020. PMID: 39720452 Free PMC article. Review.
-
Validation of Three Platelet Function Tests for Bleeding Risk Stratification During Dual Antiplatelet Therapy Following Coronary Interventions.Clin Cardiol. 2016 Jul;39(7):385-90. doi: 10.1002/clc.22540. Epub 2016 Jun 29. Clin Cardiol. 2016. PMID: 27355612 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous